{"id":"NCT00678392","sponsor":"Pfizer","briefTitle":"Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer","officialTitle":"AXITINIB (AG-013736) AS SECOND LINE THERAPY FOR METASTATIC RENAL CELL CANCER: AXIS TRIAL","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-09-03","primaryCompletion":"2010-08-31","completion":"2016-02-25","firstPosted":"2008-05-15","resultsPosted":"2012-03-27","lastUpdate":"2019-01-09"},"enrollment":723,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Kidney Neoplasms"],"interventions":[{"type":"DRUG","name":"Axitinib (AG-013736)","otherNames":[]},{"type":"DRUG","name":"Sorafenib","otherNames":[]}],"arms":[{"label":"Axitinib","type":"EXPERIMENTAL"},{"label":"Sorafenib","type":"ACTIVE_COMPARATOR"}],"summary":"The study is designed to demonstrate that axitinib (AG-013736) is superior to sorafenib in delaying tumor progression in patients with metastatic renal cell cancer after failure of one first line regimen.","primaryOutcome":{"measure":"Progression-Free Survival (PFS)","timeFrame":"From initiation of treatment up to follow-up period (up to 3 years)","effectByArm":[{"arm":"Axitinib 5 mg","deltaMin":6.7,"sd":null},{"arm":"Sorafenib 400 mg","deltaMin":4.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":2},"locations":{"siteCount":294,"countries":["United States","Australia","Austria","Brazil","Canada","China","France","Germany","Greece","India","Ireland","Italy","Japan","Poland","Russia","Singapore","Slovakia","South Korea","Spain","Sweden","Taiwan","United Kingdom"]},"refs":{"pmids":["37526095","32363929","31072748","28410911","27238653","25577718","24823696","23630366","23598172","23579211","22056247"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":146,"n":359},"commonTop":["Diarrhoea","Palmar-plantar erythrodysaesthesia syndrome","Fatigue","Hypertension","Decreased appetite"]}}